Acurx Pharmaceuticals Inc. (NASDAQ: ACXP)
$0.7197
+0.0207 ( +2.81% ) 155.3K
Acurx Pharmaceuticals Inc is a clinical stage biopharmaceutical company developing a new class of antibiotics for infections caused by bacteria listed as priority pathogens by the World Health Organization, Centers for Disease Control and Prevention and Food and Drug Administration.
Market Data
Open
$0.7197
Previous close
$0.6990
Volume
155.3K
Market cap
$14.03M
Day range
$0.6810 - $0.7350
52 week range
$0.6800 - $4.5300
SEC Filings
| Form Type | Description | Pages | Date |
|---|---|---|---|
| s-1/a | Registration statements | 7 | Mar 29, 2024 |
| 8-k | 8K-related | 15 | Mar 18, 2024 |
| s-1 | Registration statements | 5 | Mar 18, 2024 |
| 10-k | Annual reports | 77 | Mar 15, 2024 |
| s-8 | Registration statements | 6 | Mar 15, 2024 |
| sc | Insider transactions | 1 | Feb 14, 2024 |